Access cutting-edge asthma treatment through this clinical trial at a research site in Sheffield. Study-provided care at no cost to qualified participants.
Access asthma specialists in Sheffield at no cost
This study follows strict safety protocols and ethical guidelines
All study-related asthma treatment provided free
This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to standard of care therapy on preventing or slowing the rate of lung function decline in adult patients with uncontrolled moderate to severe asthma. The estimated duration is 4±1 weeks of screening and run-in period, followed by a 3-year double blinded treatment period. There will be a post-treatment follow-up (FU) period up to 12 weeks.
Sponsor: Sanofi
Check if you qualify for this asthma clinical trial in Sheffield, AL
If you're searching for asthma treatment options in Sheffield, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sheffield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.